UBS Group’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $588K | Sell |
190,208
-2,084
| -1% | -$6.44K | ﹤0.01% | 4721 |
|
|
2025
Q1 | $671K | Buy |
192,292
+91,287
| +90% | +$319K | ﹤0.01% | 4469 |
|
|
2024
Q4 | $330K | Sell |
101,005
-67,369
| -40% | -$220K | ﹤0.01% | 4962 |
|
|
2024
Q3 | $648K | Buy |
168,374
+112,709
| +202% | +$434K | ﹤0.01% | 3912 |
|
|
2024
Q2 | $172K | Sell |
55,665
-79,158
| -59% | -$245K | ﹤0.01% | 4648 |
|
|
2024
Q1 | $348K | Sell |
134,823
-5,148
| -4% | -$13.3K | ﹤0.01% | 4340 |
|
|
2023
Q4 | $350K | Buy |
139,971
+77,353
| +124% | +$193K | ﹤0.01% | 4230 |
|
|
2023
Q3 | $127K | Sell |
62,618
-5,549
| -8% | -$11.3K | ﹤0.01% | 4568 |
|
|
2023
Q2 | $157K | Buy |
68,167
+31,502
| +86% | +$72.5K | ﹤0.01% | 4612 |
|
|
2023
Q1 | $111K | Buy |
36,665
+13,376
| +57% | +$40.5K | ﹤0.01% | 4772 |
|
|
2022
Q4 | $54.3K | Buy |
+23,289
| New | +$54.3K | ﹤0.01% | 5541 |
|
|
2022
Q2 | – | Sell |
-1,298
| Closed | -$4K | – | 9184 |
|
|
2022
Q1 | $4K | Sell |
1,298
-32,810
| -96% | -$101K | ﹤0.01% | 8206 |
|
|
2021
Q4 | $132K | Buy |
+34,108
| New | +$132K | ﹤0.01% | 4980 |
|
|
2021
Q3 | – | Sell |
-62,310
| Closed | -$189K | – | 8297 |
|
|
2021
Q2 | $189K | Sell |
62,310
-10,805
| -15% | -$32.8K | ﹤0.01% | 4371 |
|
|
2021
Q1 | $244K | Buy |
73,115
+55,189
| +308% | +$184K | ﹤0.01% | 4375 |
|
|
2020
Q4 | $64K | Buy |
17,926
+10,913
| +156% | +$39K | ﹤0.01% | 4977 |
|
|
2020
Q3 | $22K | Sell |
7,013
-317,279
| -98% | -$995K | ﹤0.01% | 5366 |
|
|
2020
Q2 | $590K | Sell |
324,292
-45,856
| -12% | -$83.4K | ﹤0.01% | 3258 |
|
|
2020
Q1 | $374K | Buy |
370,148
+126,930
| +52% | +$128K | ﹤0.01% | 3443 |
|
|
2019
Q4 | $676K | Buy |
243,218
+57,094
| +31% | +$159K | ﹤0.01% | 3655 |
|
|
2019
Q3 | $284K | Buy |
186,124
+19,715
| +12% | +$30.1K | ﹤0.01% | 4110 |
|
|
2019
Q2 | $346K | Buy |
166,409
+160,650
| +2,790% | +$334K | ﹤0.01% | 3772 |
|
|
2019
Q1 | $21K | Buy |
5,759
+1,154
| +25% | +$4.21K | ﹤0.01% | 5431 |
|
|
2018
Q4 | $18K | Buy |
4,605
+3,218
| +232% | +$12.6K | ﹤0.01% | 5941 |
|
|
2018
Q3 | $13K | Sell |
1,387
-36,375
| -96% | -$341K | ﹤0.01% | 6106 |
|
|
2018
Q2 | $276K | Sell |
37,762
-4,203
| -10% | -$30.7K | ﹤0.01% | 3910 |
|
|
2018
Q1 | $210K | Sell |
41,965
-2,396
| -5% | -$12K | ﹤0.01% | 3958 |
|
|
2017
Q4 | $224K | Sell |
44,361
-8,205
| -16% | -$41.4K | ﹤0.01% | 3941 |
|
|
2017
Q3 | $326K | Buy |
52,566
+52,451
| +45,610% | +$325K | ﹤0.01% | 3721 |
|
|
2017
Q2 | $0 | Sell |
115
-1,739
| -94% | – | ﹤0.01% | 6656 |
|
|
2017
Q1 | $6K | Buy |
+1,854
| New | +$6K | ﹤0.01% | 5948 |
|
|
2016
Q4 | – | Sell |
-5,500
| Closed | -$19K | – | 6733 |
|
|
2016
Q3 | $19K | Sell |
5,500
-578
| -10% | -$2K | ﹤0.01% | 5422 |
|
|
2016
Q2 | $21K | Buy |
6,078
+345
| +6% | +$1.19K | ﹤0.01% | 5378 |
|
|
2016
Q1 | $24K | Sell |
5,733
-2,326
| -29% | -$9.74K | ﹤0.01% | 5238 |
|
|
2015
Q4 | $35K | Buy |
8,059
+547
| +7% | +$2.38K | ﹤0.01% | 5058 |
|
|
2015
Q3 | $46K | Sell |
7,512
-6,949
| -48% | -$42.6K | ﹤0.01% | 4782 |
|
|
2015
Q2 | $172K | Buy |
14,461
+13,592
| +1,564% | +$162K | ﹤0.01% | 3973 |
|
|
2015
Q1 | $15K | Sell |
869
-995
| -53% | -$17.2K | ﹤0.01% | 5595 |
|
|
2014
Q4 | $28K | Buy |
+1,864
| New | +$28K | ﹤0.01% | 5209 |
|